In our studies, GPC3 immunoreactivity was detected in 103 of 136 HCC cases (75.7%), and GPC3 expression was closely related with HBsAg positivity, but not with sex, HCC differentiation, age, serum AFP level, tumor size, and extrahepatic metastasis. The gene discussed is GPC3; the disease is hepatocellular carcinoma.